These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9620557)

  • 1. The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53.
    Dugimont T; Montpellier C; Adriaenssens E; Lottin S; Dumont L; Iotsova V; Lagrou C; Stéhelin D; Coll J; Curgy JJ
    Oncogene; 1998 May; 16(18):2395-401. PubMed ID: 9620557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proinsulin-like growth factor-II overexpression does not alter monoallelic H19 gene expression in transfected human embryonic kidney fibroblasts.
    Kiess W; Paquette J; Koepf G; Wolf E; Deal C
    Biochem Biophys Res Commun; 1999 Feb; 255(2):226-30. PubMed ID: 10049690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
    Wang Q; Beck WT
    Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TATA-less promoters of some Ets-family genes are efficiently repressed by wild-type p53.
    Iotsova V; Crépieux P; Montpellier C; Laudet V; Stehelin D
    Oncogene; 1996 Dec; 13(11):2331-7. PubMed ID: 8957074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of fibronectin gene expression by the p53 tumor suppressor protein.
    Iotsova V; Stehelin D
    Cell Growth Differ; 1996 May; 7(5):629-34. PubMed ID: 8732672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
    Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
    Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid hormone-related protein gene expression in human squamous carcinoma cells is repressed by mutant isoforms of p53.
    Foley J; Wysolmerski JJ; Broadus AE; Philbrick WM
    Cancer Res; 1996 Sep; 56(17):4056-62. PubMed ID: 8752179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
    Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
    Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a p53-dependent negative response element in the bcl-2 gene.
    Miyashita T; Harigai M; Hanada M; Reed JC
    Cancer Res; 1994 Jun; 54(12):3131-5. PubMed ID: 8205530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53-dependent repression of the human MCL-1 gene encoding an anti-apoptotic member of the BCL-2 family: the role of Sp1 and of basic transcription factor binding sites in the MCL-1 promoter.
    Pietrzak M; Puzianowska-Kuznicka M
    Biol Chem; 2008 Apr; 389(4):383-93. PubMed ID: 18208354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of hepatitis B virus X gene on p21(WAF1) expression through p53-dependent and p53-independent pathways].
    Lin J; Zhu MH; Qu JH; Li FM; Ni CR
    Ai Zheng; 2004 Jul; 23(7):749-55. PubMed ID: 15248906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
    Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
    Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis.
    Zhang L; Kashanchi F; Zhan Q; Zhan S; Brady JN; Fornace AJ; Seth P; Helman LJ
    Cancer Res; 1996 Mar; 56(6):1367-73. PubMed ID: 8640827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mouse thymidylate synthase promoter activity by the wild-type p53 tumor suppressor protein.
    Lee Y; Chen Y; Chang LS; Johnson LF
    Exp Cell Res; 1997 Aug; 234(2):270-6. PubMed ID: 9260894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus X gene expression is activated by X protein but repressed by p53 tumor suppressor gene product in the transient expression system.
    Takada S; Kaneniwa N; Tsuchida N; Koike K
    Virology; 1996 Feb; 216(1):80-9. PubMed ID: 8615009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.
    Manoharan H; Babcock K; Pitot HC
    Mol Carcinog; 2004 Sep; 41(1):1-16. PubMed ID: 15352122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H19 and Igf2 monoallelic expression is regulated in two distinct ways by a shared cis acting regulatory region upstream of H19.
    Srivastava M; Hsieh S; Grinberg A; Williams-Simons L; Huang SP; Pfeifer K
    Genes Dev; 2000 May; 14(10):1186-95. PubMed ID: 10817754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
    Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
    J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wild-type p53 down-regulates transcription from oncogenic human papillomavirus promoters through the epithelial specific enhancer.
    Desaintes C; Hallez S; Detremmerie O; Burny A
    Oncogene; 1995 Jun; 10(11):2155-61. PubMed ID: 7784059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
    Li C; Lin M; Liu J
    Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.